Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors

P. B. MINER JR; L. A. MCKEAN; R. D. GIBB; G. N. ERASALA; D. L. RAMSEY; J. W. MCRORIE

首页> 外文期刊>Alimentary Pharmacology & Therapeutics >Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors

【24h】

Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors

机译：奥美拉唑-镁20.6 mg在控制胃酸方面优于兰索拉唑15 mg：非处方药质子泵抑制剂的比较

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aliment Pharmacol Ther 31, 846–851

机译：Aliment Pharmacol Ther 31，846–851

著录项

来源
《Alimentary Pharmacology & Therapeutics》 |2010年第8期|p.846-851|共6页
作者
P. B. MINER JR; L. A. MCKEAN; R. D. GIBB; G. N. ERASALA; D. L. RAMSEY; J. W. MCRORIE;
展开▼
作者单位

Oklahoma Foundation for Digestive Research, Oklahoma City, OK, USA;

The Procter & Gamble Company, Cincinnati, OH, USA;

The Procter & Gamble Company, Cincinnati, OH, USA;

The Procter & Gamble Company, Cincinnati, OH, USA;

The Procter & Gamble Company, Cincinnati, OH, USA;

The Procter & Gamble Company, Cincinnati, OH, USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
专利

1. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors. [J] . Miner PB Jr, McKean LA, Gibb RD, Alimentary pharmacology & therapeutics. . 2010,第8期

机译：奥美拉唑-镁20.6 mg在控制胃酸方面优于兰索拉唑15 mg：比较非处方剂量的质子泵抑制剂。
2. High-Dose Proton Pump Inhibitors Are Superior to Standard-Dose Proton Pump Inhibitors in High-Risk Patients With Bleeding Ulcers and High-Risk Stigmata After Endoscopic Hemostasis [J] . Zhenhua Zhu, Yongkang Lai, Liu Ouyang, Clinical and Translational Gastroenterology . 2021,第1期

机译：高剂量质子泵抑制剂优于高危患者的标准剂量质子泵抑制剂，在内窥镜止血后出血溃疡和高风险的柱状
3. Stronger inhibition of gastric acid secretion by lafutidine, a novel H(2) receptor antagonist, than by the proton pump inhibitor lansoprazole. [J] . Yamagishi H, Koike T, Ohara S, World journal of gastroenterology : . 2008,第15期

机译：与新型的质子泵抑制剂兰索拉唑相比，拉夫替丁（一种新型的H（2）受体拮抗剂）对胃酸分泌的抑制作用更强。
4. A comparison of synthesized corrosion inhibitors with commercial oilfield inhibitor in 15 hydrochloric acid solution for N80 tubing steel [C] . AMBRISH SINGH . -1

机译：N80钢铁15％盐酸溶液中商业油田抑制剂合成腐蚀抑制剂的比较
5. Implementation of an Evidence-Based Clinical Decision Tool to Improve Guideline Adherence and Drug Dosing Accuracy of Proton Pump Inhibitors in the Hospital Setting [D] . Morris, Kathleen E. 2019

机译：实施基于证据的临床决策工具，以提高医院环境中质子泵抑制剂的指南依从性和药物剂量准确性
6. High-Dose Proton Pump Inhibitors Are Superior to Standard-Dose Proton Pump Inhibitors in High-Risk Patients With Bleeding Ulcers and High-Risk Stigmata After Endoscopic Hemostasis [O] . Zhenhua Zhu, Yongkang Lai, Liu Ouyang, 2021

机译：高剂量质子泵抑制剂优于高危患者的标准剂量质子泵抑制剂在内窥镜止血后出血溃疡和高风险的柱状
7. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors [O] . P.B. MINER JR, L.A. MCKEAN, R.D. GIBB, 2010

机译：Omeprazole-Mg 20.6mg优于Lansoprazole 15mg，用于控制胃酸：质子泵抑制剂的逆计剂量的比较

Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors

摘要

著录项

相似文献

相关主题

期刊订阅